絞り込み

16545

広告

「中国版GPS」衛星打ち上げ 成功の様子を公開

中国は19日、「中国版GPS」とも呼ばれるシステムに利用する衛星の打ち上げに成功し、その様子を一部の外国メディアに公開しました。宇宙分野の技術力の高まりをアピー...

  1. 【要指導・一般薬部会】鼻過敏症治療薬「フ...
  2. 【要指導・一般薬部会】鼻過敏症治療薬「フ...
  3. 【中国四国支部学術大会で報告】疑義照会簡...
  4. 12月13~14日に「第3回DIA再生医...

ニュース一覧

The role of mTOR inhibitors in preventing epileptogenesis in patients with TSC: Current evidence and future perspectives.

著者 Schubert-Bast S , Rosenow F , Klein KM , Reif PS , Kieslich M , Strzelczyk A
Epilepsy Behav.2018 Jun 22 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (20view , 0users)

Full Text Sources

Miscellaneous

Tuberous sclerosis complex (TSC) is one of the most common genetic causes of epilepsy. Mutations in the TSC1 or TSC2 genes lead to the dysregulation of the mechanistic target of rapamycin (mTOR) pathway. This mTOR pathway hyperactivation is associated with several processes resulting in epileptic conditions. The occurrence of seizures and their treatment outcomes seem to play a crucial role in cognitive and behavioral developments in patients with TSC. Mechanistic target of rapamycin inhibitors have been proven to be effective in epilepsy treatment in individuals with TSC. Specifically, because of their disease-modifying mechanism of action, they have the capability to prevent epileptogenesis in patients with TSC. This article will provide an overview of the current evidence of and delineate future perspectives for mTOR inhibitors and their role in preventing epileptogenesis.
PMID: 29941212 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード